Grant: Network for Global Governance Research on Infectious Diseases - LOI

Global governance fora that enable global policy coordination play an important role in supporting Canada and the international community in addressing infectious disease challenges such as antimicrobial resistance (AMR). The challenges posed by AMR are complex as they rely on inter-sectoral policy synchrony across public health, agricultural and pharmaceutical policy internationally. The goal of our proposal is to establish a network on Global Governance Research on Infectious Disease in which social and health scientists, disease modelers and knowledge users collaborate to develop an interdisciplinary and cross-sectoral research lens whose objectives are to: 1.Analyze models of global health governance and accountability by comparing case studies with variable outcomes to clarify the lessons learned and identify best governance practice; 2.Compare policy stewardship strategies to address issues of the global commons for AMR in food and agriculture, industrial processes and healthcare practice to identify effective international standard setting approaches and incentives that support compliance; 3.Model a range of infectious disease and AMR strategies to forecast their policy impact in preventing, managing and combating infectious disease. As members of a proposed World Health Organization Collaborating Centre on Global Governance of Antimicrobial Resistance, the applicants will engage in synergistic research that supports global monitoring of country actions on AMR. The WHOCC will support the collaboration of the GGRID network members with the WHO, international researchers and global multi-lateral organizations. The GGRID network will generate evidence on strategies that foster global governance, accountability and political mobilization to foster and promote global collective action. Evidence generated will enhance global and Canadian networks' efforts to align state-level policies with global strategies to address the threats of infectious diseases and AMR.